Matinas BioPharma Holdings (FRA:6LJ0) Short-Term Capital Lease Obligation : €0.73 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Matinas BioPharma Holdings Short-Term Capital Lease Obligation?

Matinas BioPharma Holdings's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was €0.73 Mil.

Matinas BioPharma Holdings's quarterly Short-Term Capital Lease Obligation increased from Sep. 2024 (€0.67 Mil) to Dec. 2024 (€0.73 Mil) and increased from Dec. 2024 (€0.73 Mil) to Mar. 2025 (€0.73 Mil).

Matinas BioPharma Holdings's annual Short-Term Capital Lease Obligation increased from Dec. 2022 (€0.54 Mil) to Dec. 2023 (€0.61 Mil) and increased from Dec. 2023 (€0.61 Mil) to Dec. 2024 (€0.73 Mil).

Matinas BioPharma Holdings Short-Term Capital Lease Obligation Historical Data

The historical data trend for Matinas BioPharma Holdings's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Matinas BioPharma Holdings Short-Term Capital Lease Obligation Chart

Matinas BioPharma Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.35

0.50

0.54

0.61

0.73

Matinas BioPharma Holdings Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.63	0.66	0.67	0.73	0.73

Matinas BioPharma Holdings Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Matinas BioPharma Holdings Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Matinas BioPharma Holdings's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Matinas BioPharma Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Matinas BioPharma Holdings Inc (FRA:6LJ0) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

MTNB:USA

Address

1545 Route 206 South, Suite 302, Bedminster, NJ, USA, 07921

Website

https://www.matinasbiopharma.com

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Matinas BioPharma Holdings Headlines

No Headlines